Poop pills? FMT trial aims to calm Immunotherapy's gut wreckage
NCT ID NCT04883762
First seen Oct 31, 2025 · Last updated May 24, 2026 · Updated 25 times
Summary
This early study tests whether a fecal transplant from a healthy donor can safely ease severe diarrhea caused by immune checkpoint inhibitors (ICIs) in cancer patients. Four adults whose diarrhea did not improve with standard treatments received the transplant during a colonoscopy. The goal is to see if healthy bacteria can restore gut health and reduce symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FECAL MICROBIOTA TRANSPLANTATION (FMT) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.